Galligan Andrew H
Insider CIK 1417976 · DDXS Director · OOMA Director · NVRO VP of Finance , CFO · ACLX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OOMA OOMA INC | A Award | 2026-06-04 | 2026-06-08 | 9,743 | — | $0 | 250,824 | SEC↗ |
| ACLX Arcellx, Inc. | D To issuer deriv | 2026-04-28 | 2026-04-28 | 16,829 | — | $0 | 0 | SEC↗ |
| ACLX Arcellx, Inc. | D To issuer deriv | 2026-04-28 | 2026-04-28 | 1,784 | — | $0 | 0 | SEC↗ |
| ACLX Arcellx, Inc. | U Tender | 2026-04-28 | 2026-04-28 | 5,000 | — | $0 | 0 | SEC↗ |
| OOMA OOMA INC | S Sale | 2025-06-23 | 2025-06-24 | 12,407 | $12.43 | $154.2K | 241,081 | SEC↗ |
| OOMA OOMA INC | A Award | 2025-06-05 | 2025-06-09 | 11,556 | — | $0 | 253,488 | SEC↗ |
| ACLX Arcellx, Inc. | A Award deriv | 2025-05-29 | 2025-05-30 | 1,784 | — | $0 | 1,784 | SEC↗ |
| ACLX Arcellx, Inc. | A Award deriv | 2025-03-18 | 2025-03-20 | 16,829 | — | $0 | 16,829 | SEC↗ |
| OOMA OOMA INC | M Exercise deriv | 2024-12-17 | 2024-12-19 | 35,000 | — | $0 | 0 | SEC↗ |
| OOMA OOMA INC | S Sale | 2024-12-17 | 2024-12-19 | 14,824 | $14.56 | $215.8K | 241,932 | SEC↗ |
| OOMA OOMA INC | M Exercise | 2024-12-17 | 2024-12-19 | 35,000 | $6.04 | $211.4K | 256,756 | SEC↗ |
| OOMA OOMA INC | A Award | 2024-06-06 | 2024-06-07 | 19,762 | — | $0 | 221,833 | SEC↗ |
| OOMA OOMA INC | A Award | 2023-06-01 | 2023-06-05 | 11,783 | — | $0 | 202,071 | SEC↗ |
| OOMA OOMA INC | A Award | 2022-06-01 | 2022-06-03 | 11,355 | — | $0 | 190,288 | SEC↗ |
| OOMA OOMA INC | A Award | 2021-06-02 | 2021-06-04 | 7,498 | — | $0 | 178,933 | SEC↗ |
| NVRO NEVRO CORP | F Tax w/h | 2020-06-04 | 2020-06-08 | 2,311 | $121.53 | $280.9K | 59,179 | SEC↗ |
| OOMA OOMA INC | A Award | 2020-06-03 | 2020-06-05 | 10,451 | — | $0 | 171,435 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2020-02-28 | 2020-03-03 | 8,000 | — | $0 | 33,394 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2020-02-28 | 2020-03-03 | 8,000 | $3.60 | $28.8K | 61,490 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2020-01-08 | 2020-01-10 | 17,718 | — | $0 | 0 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2020-01-08 | 2020-01-10 | 17,718 | $63.23 | $1.12M | 71,208 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2020-01-08 | 2020-01-10 | 17,718 | $120.11 | $2.13M | 53,490 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2020-01-06 | 2020-01-08 | 2,782 | — | $0 | 17,718 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2020-01-06 | 2020-01-08 | 2,782 | $120.00 | $333.8K | 53,490 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2020-01-06 | 2020-01-08 | 2,782 | $63.23 | $175.9K | 56,272 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2019-11-25 | 2019-11-26 | 12,000 | — | $0 | 20,500 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2019-11-25 | 2019-11-26 | 12,000 | $110.39 | $1.32M | 53,490 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2019-11-25 | 2019-11-26 | 12,000 | $63.23 | $758.8K | 65,490 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2019-11-11 | 2019-11-13 | 6,522 | — | $0 | 14,941 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2019-11-11 | 2019-11-13 | 12,000 | — | $0 | 32,500 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2019-11-11 | 2019-11-13 | 7,002 | $103.31 | $723.4K | 65,010 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2019-11-11 | 2019-11-13 | 10,345 | $103.85 | $1.07M | 54,665 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2019-11-11 | 2019-11-13 | 1,175 | $104.74 | $123.1K | 53,490 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2019-11-11 | 2019-11-13 | 12,000 | $63.23 | $758.8K | 72,012 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2019-11-11 | 2019-11-13 | 6,522 | $18.00 | $117.4K | 60,012 | SEC↗ |
| NVRO NEVRO CORP | F Tax w/h | 2019-11-01 | 2019-11-05 | 1,713 | $86.63 | $148.4K | 53,490 | SEC↗ |
| OOMA OOMA INC | S Sale | 2019-09-23 | 2019-09-23 | 25,000 | $10.50 | $262.5K | 160,984 | SEC↗ |
| OOMA OOMA INC | S Sale | 2019-09-10 | 2019-09-11 | 25,000 | $12.31 | $307.8K | 185,984 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2019-07-16 | 2019-07-17 | 2,500 | — | $0 | 41,394 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2019-07-16 | 2019-07-17 | 2,500 | $3.60 | $9.0K | 55,203 | SEC↗ |
| OOMA OOMA INC | M Exercise deriv | 2019-07-08 | 2019-07-09 | 114,943 | — | $0 | 0 | SEC↗ |
| OOMA OOMA INC | M Exercise deriv | 2019-07-08 | 2019-07-09 | 19,157 | — | $0 | 0 | SEC↗ |
| OOMA OOMA INC | M Exercise | 2019-07-08 | 2019-07-09 | 19,157 | $0.90 | $17.2K | 96,041 | SEC↗ |
| OOMA OOMA INC | M Exercise | 2019-07-08 | 2019-07-09 | 114,943 | $0.90 | $103.4K | 210,984 | SEC↗ |
| OOMA OOMA INC | A Award | 2019-06-10 | 2019-06-12 | 9,607 | — | $0 | 76,884 | SEC↗ |
| NVRO NEVRO CORP | A Award | 2019-05-28 | 2019-05-30 | 8,564 | — | $0 | 52,703 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2019-01-04 | 2019-01-08 | 11,004 | — | $0 | 0 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2019-01-04 | 2019-01-08 | 11,004 | $1.44 | $15.8K | 44,139 | SEC↗ |
| NVRO NEVRO CORP | F Tax w/h | 2018-11-01 | 2018-11-02 | 2,457 | $49.40 | $121.4K | 33,135 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2018-07-18 | 2018-07-20 | 7,400 | — | $0 | 11,004 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2018-07-18 | 2018-07-20 | 7,400 | $1.44 | $10.7K | 35,592 | SEC↗ |
| OOMA OOMA INC | A Award | 2018-06-06 | 2018-06-07 | 10,912 | — | $0 | 67,277 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2018-05-14 | 2018-05-16 | 7,000 | — | $0 | 21,463 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2018-05-14 | 2018-05-16 | 7,000 | $18.00 | $126.0K | 35,192 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2018-05-14 | 2018-05-16 | 7,000 | $76.14 | $533.0K | 28,192 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2018-03-01 | 2018-03-05 | 7,000 | — | $0 | 28,463 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2018-03-01 | 2018-03-05 | 5,540 | $79.90 | $442.6K | 29,652 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2018-03-01 | 2018-03-05 | 7,000 | $18.00 | $126.0K | 35,192 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2018-03-01 | 2018-03-05 | 1,460 | $80.87 | $118.1K | 28,192 | SEC↗ |
| NVRO NEVRO CORP | A Award deriv | 2017-11-14 | 2017-11-16 | 26,000 | — | $0 | 26,000 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2017-11-14 | 2017-11-16 | 7,000 | — | $0 | 35,463 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-11-14 | 2017-11-16 | 7,000 | $75.11 | $525.8K | 28,192 | SEC↗ |
| NVRO NEVRO CORP | A Award | 2017-11-14 | 2017-11-16 | 13,000 | — | $0 | 28,192 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2017-11-14 | 2017-11-16 | 7,000 | $18.00 | $126.0K | 35,192 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2017-11-09 | 2017-11-13 | 4,000 | — | $0 | 18,404 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2017-11-09 | 2017-11-13 | 4,000 | $1.44 | $5.8K | 15,192 | SEC↗ |
| NVRO NEVRO CORP | F Tax w/h | 2017-11-01 | 2017-11-03 | 641 | $88.99 | $57.0K | 11,192 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2017-08-14 | 2017-08-16 | 204 | — | $0 | 42,463 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2017-08-14 | 2017-08-16 | 6,144 | — | $0 | 36,286 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2017-08-14 | 2017-08-16 | 652 | — | $0 | 43,894 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2017-08-14 | 2017-08-16 | 652 | $3.60 | $2.3K | 12,485 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2017-08-14 | 2017-08-16 | 204 | $18.00 | $3.7K | 18,833 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-08-14 | 2017-08-16 | 7,000 | $82.31 | $576.2K | 11,833 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2017-08-14 | 2017-08-16 | 6,144 | $3.60 | $22.1K | 18,629 | SEC↗ |
| OOMA OOMA INC | A Award | 2017-06-20 | 2017-06-22 | 12,805 | — | $0 | 56,365 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2017-05-15 | 2017-05-16 | 7,500 | — | $0 | 44,546 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-05-15 | 2017-05-16 | 1,306 | $76.40 | $99.8K | 11,833 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2017-05-15 | 2017-05-16 | 7,500 | $3.60 | $27.0K | 19,333 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-05-15 | 2017-05-16 | 3,496 | $74.69 | $261.1K | 15,837 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-05-15 | 2017-05-16 | 2,698 | $75.55 | $203.8K | 13,139 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2017-05-09 | 2017-05-11 | 5,000 | — | $0 | 22,404 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2017-05-09 | 2017-05-11 | 5,000 | $1.44 | $7.2K | 11,833 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-04-03 | 2017-04-05 | 14,297 | $95.04 | $1.36M | 6,833 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-04-03 | 2017-04-05 | 9,166 | $94.32 | $864.5K | 21,130 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-04-03 | 2017-04-05 | 6,537 | $93.39 | $610.5K | 30,296 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2017-03-01 | 2017-03-03 | 7,500 | — | $0 | 52,046 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-03-01 | 2017-03-03 | 7,200 | $94.97 | $683.8K | 37,133 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2017-03-01 | 2017-03-03 | 300 | $95.77 | $28.7K | 36,833 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2017-03-01 | 2017-03-03 | 7,500 | $3.60 | $27.0K | 44,333 | SEC↗ |
| NVRO NEVRO CORP | A Award deriv | 2016-11-16 | 2016-11-18 | 27,333 | — | $0 | 27,333 | SEC↗ |
| NVRO NEVRO CORP | A Award | 2016-11-16 | 2016-11-18 | 6,833 | — | $0 | 36,833 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2016-11-15 | 2016-11-16 | 4,185 | — | $0 | 42,667 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2016-11-15 | 2016-11-16 | 3,315 | — | $0 | 59,546 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-11-15 | 2016-11-16 | 2,906 | $87.55 | $254.4K | 30,000 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2016-11-15 | 2016-11-16 | 3,315 | $3.60 | $11.9K | 33,315 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2016-11-15 | 2016-11-16 | 4,185 | $18.00 | $75.3K | 37,500 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-11-15 | 2016-11-16 | 200 | $84.17 | $16.8K | 37,300 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-11-15 | 2016-11-16 | 660 | $85.70 | $56.6K | 36,640 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-11-15 | 2016-11-16 | 3,734 | $86.75 | $323.9K | 32,906 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2016-08-15 | 2016-08-17 | 2,374 | — | $0 | 42,430 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2016-08-15 | 2016-08-17 | 79 | — | $0 | 62,861 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2016-08-15 | 2016-08-17 | 5,047 | — | $0 | 46,852 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2016-08-15 | 2016-08-17 | 2,374 | $3.60 | $8.5K | 32,453 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2016-08-15 | 2016-08-17 | 79 | $3.60 | $284 | 30,079 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2016-08-15 | 2016-08-17 | 5,047 | $18.00 | $90.8K | 37,500 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-08-15 | 2016-08-17 | 4,206 | $97.39 | $409.6K | 33,294 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-08-15 | 2016-08-17 | 3,194 | $98.09 | $313.3K | 30,100 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-08-15 | 2016-08-17 | 100 | $98.85 | $9.9K | 30,000 | SEC↗ |
| OOMA OOMA INC | A Award | 2016-06-16 | 2016-06-17 | 14,000 | — | $0 | 43,560 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2016-05-16 | 2016-05-18 | 10,000 | — | $0 | 27,404 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-05-16 | 2016-05-18 | 10,000 | $64.78 | $647.8K | 30,000 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2016-05-16 | 2016-05-18 | 10,000 | $1.44 | $14.4K | 40,000 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2016-03-17 | 2016-03-21 | 25,500 | — | $0 | 37,404 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2016-03-17 | 2016-03-21 | 25,500 | $1.44 | $36.7K | 30,000 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2016-03-01 | 2016-03-03 | 10,000 | — | $0 | 62,904 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-03-01 | 2016-03-03 | 1,384 | $54.81 | $75.9K | 11,614 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-03-01 | 2016-03-03 | 3,100 | $56.07 | $173.8K | 8,514 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-03-01 | 2016-03-03 | 3,314 | $56.74 | $188.0K | 5,200 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-03-01 | 2016-03-03 | 600 | $57.68 | $34.6K | 4,600 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-03-01 | 2016-03-03 | 100 | $59.06 | $5.9K | 4,500 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2016-03-01 | 2016-03-03 | 10,000 | $1.44 | $14.4K | 14,500 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-03-01 | 2016-03-03 | 1,202 | $53.90 | $64.8K | 12,998 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2016-03-01 | 2016-03-03 | 300 | $52.30 | $15.7K | 14,200 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2015-12-29 | 2016-03-03 | 4,500 | — | $0 | 72,904 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2015-12-29 | 2016-03-03 | 4,500 | $1.44 | $6.5K | 4,500 | SEC↗ |
| NVRO NEVRO CORP | A Award deriv | 2015-12-01 | 2015-12-03 | 44,500 | — | $0 | 44,500 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2015-11-17 | 2015-11-19 | 4,615 | — | $0 | 51,899 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2015-11-17 | 2015-11-19 | 4,070 | — | $0 | 44,804 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2015-11-17 | 2015-11-19 | 869 | — | $0 | 62,940 | SEC↗ |
| NVRO NEVRO CORP | M Exercise deriv | 2015-11-17 | 2015-11-19 | 10,446 | — | $0 | 77,404 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2015-11-17 | 2015-11-19 | 4,070 | $3.60 | $14.7K | 15,385 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2015-11-17 | 2015-11-19 | 10,446 | $1.44 | $15.0K | 10,446 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2015-11-17 | 2015-11-19 | 18,500 | $51.24 | $947.9K | 1,500 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2015-11-17 | 2015-11-19 | 4,615 | $18.00 | $83.1K | 20,000 | SEC↗ |
| NVRO NEVRO CORP | S Sale | 2015-11-17 | 2015-11-19 | 1,500 | $52.01 | $78.0K | 0 | SEC↗ |
| NVRO NEVRO CORP | M Exercise | 2015-11-17 | 2015-11-19 | 869 | $3.60 | $3.1K | 11,315 | SEC↗ |
| OOMA OOMA INC | A Award | 2015-07-16 | 2015-07-20 | 9,615 | — | $0 | 29,560 | SEC↗ |
| NVRO NEVRO CORP | A Award deriv | 2014-11-05 | 2014-11-07 | 56,514 | — | $0 | 56,514 | SEC↗ |
| DDXS diaDexus, Inc. | A Award deriv | 2014-05-29 | 2014-06-02 | 60,000 | — | $0 | 60,000 | SEC↗ |
| DDXS diaDexus, Inc. | A Award deriv | 2013-08-06 | 2013-08-08 | 60,000 | — | $0 | 60,000 | SEC↗ |
| DDXS diaDexus, Inc. | A Award | 2013-08-06 | 2013-08-08 | 6,500 | — | $0 | 6,500 | SEC↗ |
| DDXS diaDexus, Inc. | A Award deriv | 2012-09-20 | 2012-09-24 | 60,000 | — | $0 | 60,000 | SEC↗ |